The purpose of this study is to measure study drug levels in the bloodstream of children who are between the ages of 3 to 17 years old at the time of enrollment and to determine if the study drugs are safe and able to reduce th ...

The purpose of this study is to gather information about Hepatitis C Virus (HCV) in order to help researchers understand which drugs could be used to treat your infection in the future.

The purpose of this study is to determine drug doses for children who are at ages 3 to 17 years old at the time of enrollment and to see if the study drugs are safe and able to clear the HCV from the body.

The purpose of this study is to continue to follow the response that the body has after participating in a Gilead-sponsored HCV treatment study.

You are invited to donate your blood, urine, research data, and related information to be stored (banked) in a research specimen/data database or bank where it can be used for future research projects. The specimens/data collec ...

The study will evaluate the safety, tolerability, and effectiveness of Tenofovir Alafenamide (TAF) against hepatitis B virus in all of the enrolled children and adolescent subjects.

The goal of this study is to determine whether maralixibat is safe and effective in the treatment of Progressive Familial Intrapeatic Cholestasis (PFIC). Currently, there is no approved treatment for PFIC and available medical ...

The purpose of the study is to collect scientific data on pediatric liver transplantation to learn more about how children do after liver transplant. Collecting this data is expected to help researchers learn more about liver t ...

Pediatric liver transplantation has become the standard of care for many children with liver diseases. However, different institutions often treat and manage children with liver transplant in different ways. Currently, there ar ...

The primary objective of the study is to evaluate the long-term safety and tolerability of maralixibat.

The purpose of this study is to see whether ozanimod (RPC1063, also referred to as the ‘study drug’ or ‘study treatment’) is safe and effective for the possible treatment of Crohn’s Disease (CD) in a pediatric population. To do ...

This Clinical Trial is being conducted to assess the effects of an experimental drug (study drug) called VTX-801 intended to treat Wilson’s Disease (WD). The purpose of this clinical study is to assess what effects, good and b ...